Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mereo BioPharma Group (MREO) Research & Development: 2016-2024

Historic Research & Development for Mereo BioPharma Group (MREO) over the last 9 years, with Dec 2024 value amounting to $20.9 million.

  • Mereo BioPharma Group's Research & Development rose 34.70% to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.4 million, marking a year-over-year increase of 32.40%. This contributed to the annual value of $20.9 million for FY2024, which is 20.16% up from last year.
  • Mereo BioPharma Group's Research & Development amounted to $20.9 million in FY2024, which was up 20.16% from $17.4 million recorded in FY2023.
  • Mereo BioPharma Group's Research & Development's 5-year high stood at $31.8 million during FY2021, with a 5-year trough of $17.4 million in FY2023.
  • Its 3-year average for Research & Development is $22.6 million, with a median of $20.9 million in 2024.
  • Per our database at Business Quant, Mereo BioPharma Group's Research & Development soared by 51.29% in 2021 and then crashed by 40.89% in 2023.
  • Mereo BioPharma Group's Research & Development (Yearly) stood at $21.0 million in 2020, then spiked by 51.29% to $31.8 million in 2021, then decreased by 7.22% to $29.5 million in 2022, then tumbled by 40.89% to $17.4 million in 2023, then increased by 20.16% to $20.9 million in 2024.